DERMAI TECH

MODERNIZING AUTOIMMUNE DISORDER MANAGEMENT

About DermAi Tech

Introducing DermAi Tech, a sophisticated yet accessible app that

bridges the gap between advanced medical research and

practical healthcare solutions.

The application allows for deep understanding and management of various skin-related autoimmune diseases such as psoriasis, scleroderma, dermatomyositis, lupus, and rheumatoid arthritis.

DermAi Tech simplifies the management of skin-related autoimmune diseases by integrating cutting-edge artificial intelligence with a user-friendly interface. Designed with dual-accessibility, the platform serves two primary users: healthcare providers and their patients, enhancing diagnostic accuracy and engaging patients in their treatment plans.

Our Technology

Dual-Access

Designed for dual-access, the platform facilitates synergistic partnerships with patients and their healthcare providers, integrating vast medical data to refine diagnoses and treatment plans. Simultaneously, DermAi Tech engages patients in their medical care by enabling them to upload personal health updates and track their treatment progress in a proactive manner.

Guided by sophisticated A.I algorithms, DermAi Tech develops custom dietary and exercise plans, tailored to each patient’s specific requirements including their condition and body composition.

DermAi Tech’s innovative technology vigilantly monitors for dangerous drug interactions, providing the patient with timely alerts to prevent potential adverse effects and ensure safe treatment.

The DERMAI TECH Advantage

AI-Driven Diagnostics

The integration of AI-driven diagnostics allows healthcare providers to formulate accurate and prompt diagnoses, streamlining the diagnostic process.

Personalized Patient Care

Utilizing each patient’s personal medical history, DermAi Tech enhances the precision and efficacy of medical care.

Practitioner-Patient Accessibility

DermAi Tech’s platform serves as a dynamic tool for healthcare providers to refine diagnoses and treatment paths, while engaging patients directly in their healthcare process.

Comprehensive Care Recommendations

The DermAi Tech solution also implements holistic treatment into the patient’s treatment plan, including meal and exercise plans, thus providing patients with more comprehensive care.

Safety Monitoring

In various settings where patients may be prescribed several medications for various ailments, such as in long-term and/or elderly care homes, ensuring safe drug interaction is of the upmost importance. This integration provides both the patient and healthcare provider with peace of mind.

Dual Access

Designed for dual access, our platform facilitates a synergistic partnership between patients and health professionals. It serves as a dynamic tool for practitioners, integrating vast medical data to refine diagnoses and treatment paths.

Simultaneously, it engages patients directly in their healthcare process, enabling them to upload personal health updates and proactively track their treatment progress.

Meet the Team

Saeed Zarei

Chief Executive Officer (CEO)

As a seasoned executive with a robust background in senior management and entrepreneurial roles with a proven track record of success through innovative strategies and effective leadership, Saeed Zarei will lead DermAi Tech as it’s Chief Executive Officer.

Saeed will employ his professional and formal education in Business Administration to navigate DermAi Tech’s launch in the Canadian market, ensuring strategic alignment and excellence the rapidly evolving medical technology landscape.

Zahra Basiri

Chief Operating Officer (COO)

Zahra is an adept executive with a comprehensive background in operations and financial management, complemented by extensive medical laboratory experience. With a strong command of strategic planning, project management, and team leadership, Zahra is exceptionally qualified to lead DermAi Tech’s operations.

Zahra will oversee critical operations and foster DermAi Tech’s growth, solidifying it as a leader in the Canadian medical technology sector.

Babak Soltani

Chief Innovation Officer (CIO)

Dr. Babak Soltani is an accomplished Medical Doctor specialized in the field of Dermatology, with extensive experience in clinical and hospital settings, completed by expertise in private clinical care.

Distinguished by a dynamic blend of clinical acumen and strategic leadership, Dr. Soltani is DermAi Tech’s Chief Innovative Officer.

Dr. Soltani will spearhead innovative strategies at DermAi Tech, ensuring its successful launch in the Canadian market and continued development in medical diagnostics.

Alireza Mahmoodi Gharaee

Chief Medical Officer (CMO)

Dr. Alireza Mahmoodi Gharaee is a distinguished orthopedic surgeon, renowned for executive leadership, clinical expertise, and unwavering commitment to the advancement of healthcare excellence.

Dr. Gharaee is DermAi Tech’s Chief Medical Officer, where he will oversee the medical integrity of the Company’s offerings, ensuring sound diagnostics and enhancing patents care.

Send us a message

Pricing

DermAi Tech will sell its product on a subscription basis to healthcare practitioners, allowing for the technologies full implementation in their practice.

DermAi Tech’s pricing strategy provides patients with full access to all its features at no cost to them.